The Summary
Researchers at the University of Connecticut evaluated the ability of 20 adults to prepare and self-administer grey-market peptide semaglutide using only online instructions. Given various vials, diluents, and syringes, participants attempted a 34-step preparation and injection process. On average, participants completed only 15 out of 34 steps correctly, representing a mere 44% success rate. Common errors included mistakes that could lead to incorrect dosing, needle stick injuries, or serious infections. Furthermore, participant confidence remained low throughout, highlighting the severe safety hazards of unsupervised, DIY medical injections.
Why this is interesting
As brand-name GLP-1 drugs face shortages, many turn to cheap, unapproved 'grey market' peptides online. While some assume self-administration is simple with internet guides, this study proves otherwise: untrained users struggle dangerously with reconstitution and dosing. This debunking of the DIY safety myth shows that without professional guidance and precise measurements, patients risk underdosing, overdosing, or contamination. For readers, it is a stark warning: purchasing raw peptides online to mix at home poses a major hazard, and obtaining medications through licensed pharmacies is vital for personal safety.